In recent years, the diagnostic flow of paediatric celiac disease (CD) has changed with the introduction of reliable tissue transglutaminase autoantibody (anti‐TG2) assays [1], which have led to a decrease in small intestinal biopsy samplings. This evidence concerns the gene TGM2 and celiac disease.